PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

ABSTRACT:

SUBMITTER: Lonial S 

PROVIDER: S-EPMC10429394 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature